ORTHOPEDIATRICS CORP — Form 10-Q
Filed October 28, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 3/100
What the filing says
David R. Bailey (CEO) and Fred L. Hite (CFO/COO) certified the Q3 2026 10-Q filing dated October 28, 2026. Both officers affirmed that financial statements fairly present the company's condition and results, disclosure controls are effective, and no material weaknesses or significant deficiencies in internal control over financial reporting were identified or disclosed. This is standard Sarbanes-Oxley certification with no unusual findings.
Why this rating
Routine SOX certification exhibits; no operational, financial, or control changes disclosed. Boilerplate governance compliance document.
See more from October 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.